This article is more than 5 years old. Information may no longer be current.
Cayenne Medical Inc. reaches 50,000-implant milestone
Click Here to Manage Email Alerts
Cayenne Medical Inc. announced it has reached its 50,000 implant milestone. The announcement was made yesterday at the Arthroscopy Association of North America (AANA) 29th Fall Course in Phoenix, Ariz., according to a company press release.
Cayenne specializes in the soft tissue segment and currently offers products that address previously unmet clinical needs in knee ligament reconstruction and meniscal repair, including the AperFix System, CrossFix Meniscal Repair System and iFix System
“Our 50,000th implant represents an important milestone for Cayenne as it affirms the company’s commitment to transform the soft tissue reconstruction segment and is proof-positive that our technology platform continues to gain significant traction throughout the orthopedic industry,” James W. Hart, president and CEO of Cayenne Medical, stated in the release. “We plan to continue providing innovative sports medicine solutions that offer ease-of-use for physicians and improve quality of life for patients looking to continue their active lifestyles.”
“Cayenne Medical’s innovative suite of products has allowed me to provide patients at all activity levels with strong, reliable and less invasive knee repair,” Tal David, MD, noted in the release. “The versatility of the AperFix system in particular has allowed me to confidently perform multiple ligament reconstructions with ease.”